Liquidia Corp — Director's Dealing 2025

Jan 23, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Liquidia Corp (LQDA)
CIK: 0001819576
Period of Report: 2025-01-21

Reporting Person: Saggar Rajeev (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-01-21	Common Stock	S	2445	$13.00	Disposed	267943	Direct

Footnotes

F1: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.

F2: These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on July 18, 2022 and vested on January 18, 2025.

F3: Includes (i) 11,729 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 41,666 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 42,369 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iv) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested, and (v) 4,918 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.